| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |